Ameritas Investment Company’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $172K | Buy |
44,232
+5,000
| +13% | +$19.4K | 0.01% | 687 |
|
|
2021
Q2 | $126K | Buy |
+39,232
| New | +$126K | 0.01% | 715 |
|
|
2021
Q1 | – | Sell |
-10,782
| Closed | -$24K | – | 2253 |
|
|
2020
Q4 | $24K | Hold |
10,782
| – | – | ﹤0.01% | 422 |
|
|
2020
Q3 | $33K | Hold |
10,782
| – | – | 0.01% | 331 |
|
|
2020
Q2 | $33K | Sell |
10,782
-2,500
| -19% | -$7.65K | 0.01% | 338 |
|
|
2020
Q1 | $25K | Buy |
13,282
+2,500
| +23% | +$4.71K | ﹤0.01% | 928 |
|
|
2019
Q4 | $31K | Buy |
+10,782
| New | +$31K | 0.01% | 630 |
|